Published in N Engl J Med on November 06, 2014
A Case of Acquired Thrombotic Thrombocytopenic Purpura: Three Recurrences in 25 Years. Turk J Haematol (2015) 0.87
Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin J Am Soc Nephrol (2015) 0.81
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature. Blood (2016) 0.79
Regulation of thrombosis and vascular function by protein methionine oxidation. Blood (2015) 0.79
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome. Turk J Haematol (2016) 0.77
Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea. J Korean Med Sci (2016) 0.75
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome. Thromb J (2016) 0.75
A mechanistic investigation of thrombotic microangiopathy associated with intravenous abuse of Opana ER. Blood (2016) 0.75
The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome. Pediatr Nephrol (2016) 0.75
Thrombotic microangiopathy associated with Valproic acid toxicity. BMC Nephrol (2017) 0.75
Multiple Myeloma as the Underlying Cause of Thrombotic Microangiopathy Leading to Acute Kidney Injury: Revisiting a Very Rare Entity. J Investig Med High Impact Case Rep (2017) 0.75
Hemolytic uremic syndrome in adults: A case report. World J Crit Care Med (2017) 0.75
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 5.41
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 1.02
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 1.02
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 1.02
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 5.41
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med (2006) 4.07
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (2008) 3.74
Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood (2009) 3.18
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int (2011) 2.61
Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program (2004) 1.94
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol (2011) 1.92
Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest (2010) 1.87
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica (2007) 1.87
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol (2010) 1.83
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood (2010) 1.76
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med (2004) 1.69
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol (2009) 1.56
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf (2009) 1.52
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol (2003) 1.50
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood (2014) 1.47
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist (2007) 1.45
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica (2007) 1.39
Management of immune thrombocytopenia--something old, something new. N Engl J Med (2010) 1.39
Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol (2013) 1.32
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion (2012) 1.27
Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev (2013) 1.20
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion (2007) 1.19
Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood (2013) 1.19
Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol (2010) 1.18
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer (2013) 1.16
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion (2006) 1.14
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood (2013) 1.13
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol (2011) 1.10
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion (2009) 1.09
Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol (2010) 1.08
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy. J Am Soc Nephrol (2013) 1.04
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol (2007) 1.00
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica (2011) 0.99
Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion (2004) 0.98
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes (2007) 0.98
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol (2008) 0.97
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes (2008) 0.95
Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 0.95
An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol (2006) 0.94
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol (2011) 0.93
Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol (2010) 0.92
Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med (2008) 0.92
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion (2009) 0.92
Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet (2012) 0.91
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis (2009) 0.91
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther (2007) 0.90
Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion (2003) 0.90
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion (2011) 0.90
Drug-induced thrombocytopenia in children. Pediatr Blood Cancer (2013) 0.90
Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation (2008) 0.89
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol (2012) 0.88
Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood (2009) 0.88
Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf (2007) 0.88
A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome. Pediatr Nephrol (2013) 0.87
Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica (2008) 0.86
Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion (2009) 0.86
First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion (2013) 0.86
Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med (2004) 0.85
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol (2012) 0.85
The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career. Acad Med (2015) 0.85
Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol (2008) 0.84
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion (2008) 0.84
Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol (2007) 0.84
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol (2003) 0.84
Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. Semin Hematol (2004) 0.84
Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med (2002) 0.83
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion (2014) 0.82
Diagnosis and treatment of C3 glomerulopathy. Clin Nephrol (2013) 0.82
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol (2015) 0.81
Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher (2008) 0.81
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol (2012) 0.81
The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol (2004) 0.81
Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim. Eur J Haematol (2013) 0.81
Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica (2009) 0.81
A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher (2003) 0.81
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc (2007) 0.81
Treatment of drug-induced thrombocytopenia. Expert Opin Drug Saf (2002) 0.81
Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion (2007) 0.81
Is immune thrombocytopenic purpura less common among black Americans? Blood (2005) 0.80
Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients. Am J Hematol (2009) 0.80
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol (2005) 0.80
Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent) (2003) 0.80
Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol (2010) 0.80
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol (2008) 0.80
Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia. Haematologica (2008) 0.79
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost (2010) 0.79
Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: a case report. Am J Hematol (2007) 0.79
Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura. Eur J Haematol (2009) 0.79
Severe vitamin B-12 deficiency in a child mimicking thrombotic thrombocytopenic purpura. Pediatr Blood Cancer (2009) 0.78
Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc (2007) 0.78
Drug-induced thrombocytopenia: an updated systematic review, 2010. Drug Saf (2011) 0.77
Drug-induced thrombocytopenia: an updated systematic review, 2012. Drug Saf (2012) 0.77